Carbimazole

Chemical formula: C₇H₁₀N₂O₂S  Molecular mass: 186.232 g/mol  PubChem compound: 31072

Therapeutic indications

Carbimazole is indicated for:

Hyperthyroidism

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Carbimazole is an anti-thyroid agent. It is indicated in all conditions where reduction of thyroid function is required.

Such conditions are:

  • Hyperthyroidism.
  • Preparation for thyroidectomy in hyperthyroidism.
  • Therapy prior to and post radio-iodine treatment.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Carbimazole is contraindicated in the following cases:

Lactation

Lactation

Haematological conditions

at least one of
Blood disease
H/O: blood disorder

Severe hepatic insufficiency

Hepatic failure stage IV

History of acute pancreatitis after administration of carbimazole

Acute pancreatitis

Radio-iodine

at least one of
Iodine (123I) compounds
Iodine (125I) compounds
Iodine (131I) compounds
Iodine (131I) compounds

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: CARBIMAZOLE Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈